Syros Reports First Quarter 2020 Financial Results and Highlights Recent Accomplishments and Anticipated Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Syros Reports First Quarter 2020 Financial Results and Highlights Recent Accomplishments and Anticipated Milestones

Syros Pharmaceuticals (SYRS) Tops Q1 EPS by 4c, Revenues Beat

May 7, 2020 7:49 AM EDT

Syros Pharmaceuticals (NASDAQ: SYRS) reported Q1 EPS of ($0.39), $0.04 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $2.38 million versus the consensus estimate of $1.62 million.

While COVID-19 has created tremendous uncertainty across the globe, it has also reminded us of the critical importance of medical innovation, said Nancy Simonian,... More